CurrentRheuma
Get Weekly

Rheumatology journalCurrentRheuma coverage

Rheumatology (Oxford)

What CurrentRheuma has captured from this journal. The coverage figures describe CurrentRheuma's coverage, not the journal's output. Figures as of 14 November 2026.

CurrentRheuma holds 1,905 Briefs from Rheumatology (Oxford), most often cohort studies and cross-sectional studies.

Recent
82 Briefs
past 90 days
Archive
1,905 Briefs
research published from January 2023 to today
Editorial
–
no Weekly issue published yet

Topics

Evidence types

Shares are of the 1,905 Briefs CurrentRheuma has covered from Rheumatology (Oxford), by primary topic and study type; a Brief without a primary topic is in no topic row.

Publication activity

Latest from Rheumatology (Oxford)

All coverage, newest first

  1. Rheumatology (Oxford)

    Real-world avacopan use in ANCA-associated vasculitis: glucocorticoid exposure and healthcare resource utilization from US claims data

    Cohort studyVasculitis & PMR

  2. Rheumatology (Oxford)

    Development and validation of a text-mining-based algorithm for detection of rare hereditary periodic fever syndromes

    Diagnostic or prognostic studyAutoinflammatory & rare

  3. Rheumatology (Oxford)

    Janus Kinase inhibitors in refractory Takayasu arteritis: a systematic review and proportion meta-analysis of efficacy and safety

    Meta-analysisVasculitis & PMR

  4. Rheumatology (Oxford)

    Long-term efficacy and safety of upadacitinib in patients with polyarticular-course juvenile idiopathic arthritis: 48 week results from the SELECT-YOUTH open-label study

    Research articlePediatric

  5. Rheumatology (Oxford)

    Urinary β2-microglobulin as a prognostic and treatment-associated biomarker in anti-MDA5 antibody-positive DM with interstitial lung disease

    Diagnostic or prognostic studyMyositis

  6. Rheumatology (Oxford)

    Combination targeted therapy with Janus kinase inhibition plus biologic agents in refractory JIA: an international multi-centre case series

    Cohort studyPediatric

  7. Rheumatology (Oxford)

    Creatine and CoQ10 with physical activity on muscle function in children with myositis: a proof-of-concept trial

    Randomized controlled trialPediatric

  8. Rheumatology (Oxford)

    Endothelial IFI16 drives vasculopathy and profibrotic remodeling in systemic sclerosis by activating JAK/STAT signaling

    Research articleSystemic sclerosis

  9. Rheumatology (Oxford)

    Longitudinal trends in vaccination uptake and respiratory infection burden in systemic lupus erythematosus: a population-based cohort study

    Cohort studyLupus & APS

  10. Rheumatology (Oxford)

    Krebs Von Den Lungen-6 as a biomarker for lung disease activity and diagnosis in systemic juvenile idiopathic arthritis

    Diagnostic or prognostic studyPediatric

  11. Rheumatology (Oxford)

    Large vessel giant cell arteritis in remission: Is imaging useful as predictor for relapses?

    Cohort studyVasculitis & PMR

  12. Rheumatology (Oxford)

    Obinutuzumab in systemic sclerosis: a multicentre retrospective case series

    Cohort studySystemic sclerosis

  13. Rheumatology (Oxford)

    Prevalence and clinical associations of age-related clonal hematopoiesis in systemic sclerosis

    Case-control studySystemic sclerosis

  14. Rheumatology (Oxford)

    All-cause and cause-specific mortality in people with rare autoimmune rheumatic diseases in England using whole population data

    Cohort studyAcross diseases

  15. Rheumatology (Oxford)

    Association of platelet level and white blood cell level with coronary artery lesions persistence among patients with Kawasaki disease

    Research articlePediatric

  16. Rheumatology (Oxford)

    Combination advanced therapy use and infection risks in immune-mediated inflammatory diseases

    Cohort studyAcross diseases

  17. Rheumatology (Oxford)

    ALDH4A1 and anti-ALDH4A1 emerge as a novel antigenic axis linked to atherosclerosis in rheumatoid arthritis

    Cohort studyRA

  18. Rheumatology (Oxford)

    Comorbidity burden and its impact on physical functioning and activities of daily living in patients with systemic lupus erythematosus

    Cross-sectional studyLupus & APS

  19. Rheumatology (Oxford)

    Paint me a picture: illustrating the psychosocial impact of different juvenile idiopathic arthritis categories

    Cohort studyPediatric

  20. Rheumatology (Oxford)

    Rituximab for the treatment of calcinosis in dermatomyositis: A case series and review of the literature

    Cohort studyMyositis

  21. Rheumatology (Oxford)

    Environmental determinants of large vessel vasculitis onset: a scoping review with complementary narrative synthesis of genetic susceptibility

    Research articleVasculitis & PMR

  22. Rheumatology (Oxford)

    Five items are sufficient to assess rheumatoid arthritis disease activity by patient reported outcome measure: a computer adaptive test simulation study

    Research articleRA

  23. Rheumatology (Oxford)

    Machine learning improves 10-year prediction of atherosclerotic plaque progression and cardiovascular events in systemic lupus erythematosus

    Diagnostic or prognostic studyLupus & APS

  24. Rheumatology (Oxford)

    Serological and clinical outcomes of rituximab in antiphospholipid syndrome with or without SLE: a retrospective single-centre cohort

    Cohort studyLupus & APS

  25. Rheumatology (Oxford)

    Conductive and sensorineural hearing impairment in juvenile idiopathic arthritis: a systematic review and meta-analysis

    Meta-analysisPediatric

  26. Rheumatology (Oxford)

    Comparative effectiveness and safety of five Janus kinase inhibitors in real-world clinical practice: the multicentre ANSWER cohort

    Cohort studyRA

  27. Rheumatology (Oxford)

    Longitudinal ultrasound assesment of skeletal muscle ın systemic sclerosis: association with disease activity and severity

    Cohort studySystemic sclerosis

  28. Rheumatology (Oxford)

    Risk stratification of severe infections after remission induction therapy in idiopathic inflammatory myopathy: a multicentre MYKO study

    Diagnostic or prognostic studyMyositis

  29. Rheumatology (Oxford)

    Survival and immunomodulatory therapy in autoimmune disease-associated progressive pulmonary fibrosis: a multicenter registry (NEREA)

    Cohort studySystemic sclerosis

  30. Rheumatology (Oxford)

    Extra-renal disease patterns in lupus nephritis: clinical and serological activity confers increased risk of renal flares and damage accrual

    Cohort studyLupus & APS

  31. Rheumatology (Oxford)

    Predictors of b/tsDMARDs discontinuation and treatment response in psoriatic arthritis: results from the British Society for Rheumatology Psoriatic Arthritis Register (BSR-PsA)

    Cohort studySpondyloarthritis & PsA

  32. Rheumatology (Oxford)

    Cardioprotective mechanisms and efficacy of colchicine, methotrexate, hydroxychloroquine, sulfasalazine and leflunomide in inflammatory rheumatic and musculoskeletal diseases

    Research articleAcross diseases

  33. Rheumatology (Oxford)

    Epidemiology, autoimmune overlap and in-hospital outcomes of idiopathic inflammatory myopathies in Spain, 1997–2024

    Cohort studyMyositis

  34. Rheumatology (Oxford)

    Outcomes of systemic sclerosis with overlapping myositis: a propensity score-matched cohort study

    Cohort studySystemic sclerosis

  35. Rheumatology (Oxford)

    Obesity is more strongly associated with physical performance and body composition than sarcopenia in patients with spondyloarthritis

    Cross-sectional studySpondyloarthritis & PsA

  36. Rheumatology (Oxford)

    Respiratory syncytial virus vaccination in systemic autoimmune rheumatic diseases: a systematic review

    Meta-analysisAcross diseases

  37. Rheumatology (Oxford)

    Beyond NLRP3: expanding the spectrum of NLR-associated autoinflammatory diseases

    Cohort studyAutoinflammatory & rare

  38. Rheumatology (Oxford)

    Clinical phenotypes of ANCA-associated vasculitis using ensemble clustering: prognostic and therapeutic insights from two Japanese cohorts

    Cohort studyVasculitis & PMR

  39. Rheumatology (Oxford)

    Prevalence of dysautonomia in chronic musculoskeletal pain: a cross-sectional study

    Cross-sectional studyFibromyalgia & pain

  40. Rheumatology (Oxford)

    Remission, low disease activity and relapse in patients with juvenile-, adult- and late-onset SLE

    Cohort studyLupus & APS

All 1,905 Briefs in ExploreShowing the 40 most recently published